Side Effects: Death A Former Lilly Insider Blows the Whistle on Criminal Activity in SwedenClick Here for Additional Resources
A conversation with John Virapen
Aired LIVE on:
Thursday, 20 December 2007 Listen to internet radio with Pharmaguy on Blog Talk Radio
You may also visit this Pharma Marketing Talk Segment Page to listen to the audio podcast.
This show and ALL Pharma Marketing Talk shows are available as podcasts via PMT on iTunes (FREE!).
Click Here for Additional ResourcesGuest Bio
Background
John Virapen is now retired, after working more than 30 years in the pharma industry internationally. He has worked at the executive level for some major companies such as Eli Lilly and Novo Nordisk. His career started in Sweden where he was Managing Director for Eli Lilly Sweden AB. Virapen now lives in Germany.
Last year Virapen published a fictional novel (written in German) about corruption in the pharma industry, which created some debate. He was urged by the public to tell the true story and has now written a book of memoirs primarily outlining the criminal activities he was involved in during his active years.
The Big Fish here is Eli Lilly. A few months ago Virapen was invited by Andy Vickery, a prominent US attorney, as a fact witness in an ongoing case regarding Prozac. Virapen claims to have “damning evidence” exposing Eli Lilly bribing the regulatory board in Sweden to attain marketing approval for Prozac.
In this podcast, Virapen will reveal some of the details of this ongoing expose that few in the US are aware of.
Some Questions/Topics Discussed
- With so many options, how can you pick the most effective ones?
- How Can You Assess Their Impact vs. Traditional Channels in Driving Brand Perceptions and Performance?
- How Can You Allocate DTC Budgets to Optimize ROI?
Additional Resources
